期刊
CLINICAL LUNG CANCER
卷 21, 期 1, 页码 E1-E5出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2019.07.012
关键词
Brain metastasis; Checkpoint inhibitor; Immunotherapy; Leptomeningeal carcinomatosis; Nivolumab